Vasken Dilsizian, MD, a leading figure in nuclear medicine and molecular imaging, has recently been honored with two of the most prestigious distinctions at the Society of Nuclear Medicine and Molecular Imaging (SNMMI) 2026 Annual Meeting. As a professor of radiology and medicine at the University of Maryland School of Medicine in Baltimore, Dilsizian’s groundbreaking work has significantly advanced the field, earning him the coveted Henry N. Wagner, Jr., MD, Lectureship and the Minoshima-Pappas Transformational Leadership Award. These recognitions mark a monumental moment in his extensive career dedicated to scientific innovation, clinical excellence, and impactful leadership.
The Henry N. Wagner, Jr. Lectureship is awarded annually to an eminent leader whose pioneering contributions have greatly influenced nuclear medicine and molecular imaging. Wagner was a towering figure whose prolific 50-year career included training over 500 professionals and driving advancements in research and clinical practice. His legacy as president of the Society of Nuclear Medicine from 1970 to 1971 continues to inspire innovation and educational progress within the field. Dilsizian’s selection to deliver this lectureship underscores his profound impact and stature within the nuclear medicine community.
Complementing this honor, Dilsizian received the Minoshima-Pappas Transformational Leadership Award, which recognizes visionaries whose leadership has fundamentally reshaped nuclear medicine and molecular imaging, influencing patient care at its core. Named after Dr. Satoshi Minoshima, a past president of SNMMI, and Virginia Pappas, SNMMI’s current CEO, the award celebrates transformative figures whose innovative ideas have led to lasting benefits across the discipline. By receiving this accolade alongside the Wagner Lectureship, Dilsizian exemplifies the synergy of scientific excellence and leadership that drives the future of nuclear medicine.
Dilsizian’s scientific contributions are both numerous and far-reaching. His early research on thallium reinjection revolutionized thallium stress imaging, a technique pivotal in cardiac diagnostics. By refining this method, he enabled more precise detection of myocardial ischemia, thereby improving diagnostic accuracy and subsequent patient management strategies. His investigations into myocardial ischemia as a cause for cardiac arrest and syncope, particularly among young hypertrophic cardiomyopathy patients, led to a paradigm shift in clinical interventions, improving survival and quality of life in this vulnerable population.
At the University of Maryland, Dilsizian and his research collaborators pioneered the application of 18F-fluorodeoxyglucose (FDG) PET/CT imaging for detecting infection in left ventricular assist devices (LVADs). This innovation helped establish a non-invasive, frontline diagnostic approach for a condition traditionally difficult to identify, influencing treatment decisions and patient outcomes. The integration of FDG PET/CT into clinical practice for infection elucidation marked a significant stride toward personalized molecular imaging strategies in cardiac care.
Beyond scientific research, Dr. Dilsizian has been instrumental in elevating the quality standards of nuclear cardiology practice. He has extensively contributed to clinical guidelines and credentialing protocols that ensure uniform competence and high-quality care delivery across institutions. His input into professional training materials and textbooks has augmented educational resources, empowering a new generation of nuclear medicine specialists. Concurrently, his advocacy efforts have catalyzed regulatory reforms and legislative advances that fortify the integration of cutting-edge nuclear imaging methods into routine clinical workflows.
A committed steward of the SNMMI community for over 30 years, Dilsizian’s leadership roles have been diverse and impactful. Serving as SNMMI president from 2019 to 2020, he steered the society through the COVID-19 pandemic, organizing the first fully virtual Annual Meeting and enabling uninterrupted knowledge exchange amid unprecedented challenges. His tenure also included pivotal roles in the Cardiovascular Council, Membership Committee, and Awards Committee, along with participation in the Board of Directors and House of Delegates. His longstanding role as a reviewer for The Journal of Nuclear Medicine for more than two decades further evidences his dedication to advancing scholarly excellence.
Dr. Dilsizian’s influence extends well beyond SNMMI. He has collaborated with major government and professional bodies including the National Institutes of Health (NIH), Nuclear Regulatory Commission, American Heart Association, American College of Cardiology, and the American Society of Nuclear Cardiology (ASNC). His editorial stewardship as deputy editor of JACC Cardiovascular Imaging and board memberships for other scientific journals underscores his commitment to scientific rigor and dissemination of critical knowledge in cardiovascular nuclear medicine.
Throughout his illustrious career, Dr. Dilsizian has garnered a plethora of awards recognizing his scientific, educational, and leadership accomplishments. Highlights include the SNMMI Hermann Blumgart Pioneer Award (2014), designation as a “Master” of ASNC (2016), the Lifetime Achievement Award from the World Federation of Cardiac Imaging and Clinical Cardiology (2019), and the Mario Verani Memorial Lecture Award from ASNC (2024). His prolific scholarly output, consisting of over 280 peer-reviewed manuscripts, eleven books, and 51 book chapters, has substantially enriched the knowledge base of nuclear cardiology and molecular imaging.
Educationally, Dilsizian’s background is exemplary and varied, comprising a medical degree from Tufts University School of Medicine (1982), followed by an internal medicine residency at Georgetown University (1985). His rigorous cardiology fellowships at Boston University Medical Center and Massachusetts General Hospital and a nuclear medicine residency at NIH culminated in a leadership role as director of nuclear cardiology at NIH until 2001. Subsequently, his move to the University of Maryland expanded his impact as division chief of nuclear medicine, advancing both clinical practice and research domains.
The significance of Dr. Dilsizian’s awards was underscored by notable figures within SNMMI. Satoshi Minoshima, MD, PhD, lauded him as a role model for physician-scientists, highlighting his seminal scientific contributions to cardiovascular diagnostics and treatment paradigms. Virginia Pappas, CAE, reiterated his deservingness, noting that his leadership and innovation have driven meaningful, patient-centered advances in nuclear cardiology worldwide. Their commendations reflect the broad respect and admiration Dr. Dilsizian commands across diverse facets of the nuclear medicine landscape.
In the evolving era of precision medicine, Dr. Dilsizian’s work embodies the integration of molecular imaging technologies with patient-specific diagnostic and therapeutic approaches. His pioneering efforts have not only enhanced our capacity to diagnose and monitor cardiovascular diseases with unprecedented accuracy but also accelerated the adoption of theranostic strategies that tailor interventions to molecular signatures. This transformational leadership continues to inspire the nuclear medicine community as it navigates the promising frontiers of personalized cardiovascular care.
As nuclear medicine and molecular imaging continue to redefine the diagnostic landscape, leaders like Dr. Vasken Dilsizian exemplify the fusion of rigorous scientific inquiry with visionary governance. His honors at the SNMMI 2026 Annual Meeting serve as a testament to his lifelong dedication to research excellence, clinical innovation, and societal impact. The field eagerly anticipates further advancements fueled by his scientific insight and leadership as molecular imaging cements its role in delivering precise, transformative patient care.
Subject of Research: Nuclear Medicine, Molecular Imaging, Nuclear Cardiology, Cardiovascular Diagnostics
Article Title: Vasken Dilsizian, MD, Honored with Wagner Lectureship and Transformational Leadership Award at SNMMI 2026 Annual Meeting
News Publication Date: May 30, 2026
Web References:
Society of Nuclear Medicine and Molecular Imaging (SNMMI): snmmi.org
Image Credits: Courtesy of SNMMI
Keywords: Molecular imaging, Nuclear medicine, Nuclear cardiology, Positron emission tomography, Personalized medicine, FDG PET/CT, Thallium imaging, Myocardial ischemia, Cardiovascular diagnostics, Transformational leadership, Clinical innovation, Precision medicine
Tags: clinical excellence in molecular imagingHenry N. Wagner Jr Lectureshipimpact of nuclear medicine leadersleadership in nuclear medicineMinoshima-Pappas Transformational Leadership Awardmolecular imaging innovationsnuclear medicine advancementsscientific innovation in radiologySNMMI Annual Meeting awardsSNMMI distinguished awardsUniversity of Maryland radiology professorVasken Dilsizian honors 2026
